Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at JPMorgan Chase & Co. from $22.00 to $24.00. They now have an "overweight" rating on the stock.
D-Fend Solutions Raises $31M to Fortify Cyber Counter-Drone Technology and Market Leadership
Cellebrite Announces Participation in the UBS Global Technology and AI Conference
Cellebrite and Relativity Deliver Solutions to Transform the Mobile Data Collection Landscape
Is Cellebrite (CLBT) Poised to Develop And Sell The Next Generation Of AI Analytics Tools? [Yahoo! Finance]